SECsense Logo

AngioDynamics, Inc. 8-K Report: Key Updates from January 8, 2025

$ANGO
Form 8-K
Filed on: 2025-01-08
Source
AngioDynamics, Inc. 8-K Report: Key Updates from January 8, 2025

Based on the provided section of the financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: AngioDynamics, Inc.
  • CIK Number: 0001275187
  • SEC File Number: 000-50761
  • EIN: 11-3146460
  • Address: 14 Plaza Drive, Latham, NY 12110
  • Phone Number: 518-795-1400
  1. Filing Type:
  • Form Type: 8-K (current report)
  1. Filing Date:
  • Date of Filing: January 8, 2025
  1. Stock Information:
  • Common Stock: Par value of $0.01 per share
  • Ticker Symbol: ANGO
  • Exchange: NASDAQ
  1. Reporting Period:
  • Start Date: January 8, 2025
  • End Date: January 8, 2025

Insights:

  • The report indicates a current event filing (8-K) by AngioDynamics, which typically suggests that the company is disclosing significant events or changes that could impact investors.
  • The use of a specific date for both the start and end indicates that the information may pertain to a specific event or transaction occurring on that day.
  • The financial reporting is aligned with SEC requirements, as evidenced by the CIK number and other identifiers.

Overall, this information is relevant for stakeholders looking to assess any significant developments concerning AngioDynamics as of the specified date.